02 October 2003
GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells
Prabal K. Chatterjee, Espen O. Kvale, Nimesh S.A. Patel, Christoph ThiemermannMed Sci Monit 2003; 9(10): BR357-362 :: ID: 13216
Abstract
Background:Production of nitric oxide (NO) subsequent to expression of inducible NO synthase (iNOS) contributes to the development of ischemic renal injury and inflammation. Here we investigate the effects of GW274150, a potent, long-acting and highly selective inhibitor of iNOS activity, on NO production by primary cultures of rat proximal tubular cells (PTC).Material/Methods:Pure populations of PTC were isolated from the cortex of kidneys obtained from male Wistar rats using a combination of collagenase digestion, sieving and Percoll centrifugation. Confluent PTC cultures were incubated for 1–24 h with MEM, interferon-gamma (IFN-gamma, 100 mcg/ml), bacterial lipopolysaccharide (LPS, 10 mcg/ml) in combination after which NO production was determined. PTC were also incubated with IFN-gamma (100 mcg/ml) and LPS (10 mcg/ml) and increasing concentrations of GW274150 or L-N[sup]6[/sup]-(1-iminoethyl)lysine (L-NIL) (10 nM – 1 mM) for 24 h after which nitrite levels in the incubation medium were measured.Results:IFN-gamma and LPS in combination produced a significant, time-dependent increase in NO production. Both GW274150 and L-NIL produced a significant and concentration-dependent inhibition of NO production. However, GW274150 was markedly more potent (EC[sub]50[/sub] ~ 100 nM) than L-NIL (EC[sub]50[/sub] ~ 10 mcM).Conclusions:GW274150 inhibits NO production by primary cultures of PTCs and may therefore be useful in conditions associated with nitrosative stress of the kidney.
Keywords: Dose-Response Relationship, Drug, Enzyme Inhibitors - pharmacology, Interferon Type II - metabolism, Kidney - metabolism, Kidney Tubules - cytology, Kidney Tubules - drug effects, Kidney Tubules - metabolism, Lipopolysaccharides - metabolism, Lysine - analogs & derivatives, Lysine - metabolism, NG-Nitroarginine Methyl Ester - metabolism, Nitrates - metabolism, Nitric Oxide - metabolism, Nitric Oxide Synthase - antagonists & inhibitors, Nitric Oxide Synthase - metabolism, Nitric Oxide Synthase Type II, Nitrites - metabolism, Nitrogen - metabolism, Rats, Wistar, Sulfides - pharmacology, Time Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952